Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association - 1 Jan 2000

Li Tao, Liu Feng, Zhang Lixin, Ye Qian, Fan Xiaoping, Xue Yan, Wang Lei

Abstract excerpt

Background/Aims: The optimal duration of nucleos(t)ide analogs (NAs) therapy in chronic hepatitis B (CHB) patients remains unsatisfactory. Previous studies have confirmed the important role of host genetic factors in determining the outcome of HBV infection. This study tries to determine the role of host genetic factors in predicting response status in CHB patients discontinuing NAs according to stringent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to CD40 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Nucleosides

Share to Nucleotides

Share to Pharmacogenomic Variants

Source

Open in PubMed Open full text

Identifiers

PMID: 29451182
DOI: 10.4103/sjg.SJG_228_17
PMCID: PMC5848322

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs.PMID 29451182Read ↗

Genetic variations in the CXCR5 gene decrease the risk of clinical relapse after discontinuation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B.Semantic proximity Read ↗

Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients.Semantic proximity Read ↗

Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis BSemantic proximity Read ↗

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.Semantic proximity Read ↗

HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy.Semantic proximity Read ↗

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.Semantic proximity Read ↗

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.Semantic proximity Read ↗

Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients.Semantic proximity Read ↗

Response predictors to treatment with pegylated interferon in chronic hepatitis B.Semantic proximity Read ↗

Polymorphisms of CYP27B1 are associated with IFN efficacy in HBeAg-positive patients.Semantic proximity Read ↗

HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.